Reduce Pine Labs; target of Rs 210: Emkay Global Financial

Emkay Global Financial recommended Reduce rating on Pine Labs with a target price of Rs 210 in its research report dated November 20, 2025.

Broker Research

November 20, 2025 / 11:14 IST

reduce

26 Aug, 2025 12:21

Volume

Todays L/H

Emkay Global Financial' research report on Pine Labs

However, we expect competitive intensity to rise across both segments, as adjacent-market players are increasingly targeting these pools. In merchant acquisition, industry growth is being led by digitization of small merchants, for whom low-end devices and strong distribution capabilities are crucial success factors. While Pine Labs is ramping up shipments of low-end Mosambee devices, its distribution is still weaker than peers’, limiting its right-to-win in this segment. Its India gift-card business is profitable albeit growth-constrained, while its international business is scaling up rapidly although it operates at low and volatile margins. We model 19% revenue CAGR for FY25-28E which translates into 53% EBITDA CAGR on a low base. On FY28 estimates, the stock trades at 28.1x EV/EBITDA and 56.4x P/E. Given the rising competition, we see an unfavorable risk-reward.

Outlook

We initiate coverage on Pine Labs with REDUCE and TP of Rs 210. Pine Labs has a strong value proposition in the enterprise POS segment (supported by high customer stickiness driven by deep software integration) and dominant position in EMI aggregation (owing to its early-mover advantage).

For all recommendations report, click here